Initiating insulin in patients with type 2 diabetes

被引：22
|
作者：
Lau, Adrian N. C. [1 ]
Tang, Terence [1 ]
Halapy, Henry
Thorpe, Kevin [2 ]
Yu, Catherine H. Y. [1 ,2 ,3 ]
机构：
[1] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada
[2] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2012年 / 184卷 / 07期
关键词：
ORAL HYPOGLYCEMIC AGENTS; BEDTIME NPH INSULIN; TO-TARGET TRIAL; RANDOMIZED CONTROLLED-TRIAL; BETA-CELL FUNCTION; GLYCEMIC CONTROL; BASAL INSULIN; COMBINATION-THERAPY; SECONDARY FAILURE; STARTING INSULIN;
D O I：
10.1503/cmaj.110779
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：767 / 776
页数：10
相关论文
共 50 条
  • [41] Impact of initiating or converting to treatment with an insulin aspart analog pen on medication adherence in type 2 diabetes patients on vial/syringe insulin
    Balu, S.
    Lee, W. C.
    Cobden, D.
    Joshi, A., V
    Pashos, C. L.
    VALUE IN HEALTH, 2007, 10 (03) : A68 - A68
  • [42] Association between mild and severe hypoglycemia in people with type 2 diabetes initiating insulin
    Festa, Andreas
    Heller, Simon R.
    Seaquist, Elizabeth
    Duan, Ran
    Hadjiyianni, Irene
    Fu, Haoda
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (06) : 1047 - 1052
  • [43] Barriers and Concerns Regarding Initiating Insulin Therapy among People with Type 2 Diabetes
    Stevenson, Julia
    Xu, Emily
    Monroy-Spangenberg, Erik
    Ye, Emily
    Wood, Richard
    DIABETES, 2022, 71
  • [44] The association between depressive symptoms and time to initiating insulin in people with Type 2 diabetes
    Upsher, R.
    Lake, L.
    Forbes, A.
    Chamley, M.
    Ismail, K.
    Winkley, K.
    DIABETIC MEDICINE, 2019, 36 : 150 - 150
  • [45] Real-World Outcomes of Initiating Injectable Therapy With Insulin Glargine or Liraglutide Among Patients With Type 2 Diabetes
    Levin, Philip
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Lin, Jay
    Baser, Onur
    DIABETES, 2012, 61 : A4 - A4
  • [46] THE IMPACT OF TREATMENT MODIFICATION ON HEALTHCARE EXPENDITURE IN PATIENTS WITH TYPE-2 DIABETES INITIATING EXENATIDE BID OR INSULIN GLARGINE
    Pawaskar, M.
    Bonafede, M.
    Johnson, B. H.
    Fowler, R.
    Hoogwerf, B. J.
    VALUE IN HEALTH, 2011, 14 (03) : A95 - A95
  • [47] Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: A retrospective database analysis
    Lee, Lauren J.
    Yu, Andrew P.
    Johnson, Scott J.
    Birnbaum, Howard G.
    Atanasov, Pavel
    Buesching, Don P.
    Jackson, Jeffrey A.
    Davidson, Jaime A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (01) : 108 - 116
  • [48] Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy
    Davis, Keith L.
    Tangirala, Muralikrishna
    Meyers, Juliana L.
    Wei, Wenhui
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (09) : 1083 - 1091
  • [49] Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China
    Zhang, Puhong
    Zhang, Heng
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Lu, Juming
    Jia, Weiping
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [50] Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine using disposable pen vs exenatide
    Baser, O.
    Wei, W.
    Baser, E.
    DIABETOLOGIA, 2011, 54 : S414 - S415
12345